Federal Register / Vol. 77, No. 61 / Thursday, March 29, 2012 / Notices 19005 

Dated: March 21, 2012. 

Tammy C. Adams, 

Acting Chief, Permits and Conservation 

Division, Office of Protected Resources, 

National Marine Fisheries Service. 

[FR Doc. 2012–7600 Filed 3–28–12; 8:45 am] 

BILLING CODE 3510–22–P 

CONSUMER PRODUCT SAFETY 

COMMISSION 

Notice of Teleconference of the 

Chronic Hazard Advisory Panel on 

Phthalates and Phthalate Substitutes 

AGENCY: Consumer Product Safety 

Commission. 

ACTION: Notice of meeting. 

SUMMARY: The Consumer Product Safety 

Commission (‘‘CPSC’’ or ‘‘Commission’’) 

is announcing a teleconference and the 

seventh meeting of the Chronic Hazard 

Advisory Panel (CHAP) on phthalates 

and phthalate substitutes. The 

Commission appointed this CHAP on 

April 14, 2010, to study the effects on 

children’s health of all phthalates and 

phthalate alternatives, as used in 

children’s toys and child care articles, 

pursuant to section 108 of the Consumer 

Product Safety Improvement Act of 

2008 (CPSIA) (Pub. L. 110–314). The 

CHAP will discuss its progress toward 

completing its analysis of potential risks 

from phthalates and phthalate 

substitutes. 

DATES: The teleconference will take 

place from 11 a.m. to 1 p.m. EDT (15:00 

to 17:00 GMT) on Tuesday, April 10, 

2012. Interested members of the public 

may listen to the CHAP’s discussion. 

Members of the public will not have the 

opportunity to ask questions, comment, 

or otherwise participate in the 

teleconference. Interested parties should 

contact the CPSC project manager, 

Michael Babich, by email 

(mbabich@cpsc.gov), for call-in 

instructions no later than Friday, April 

6, 2012. 

FOR FURTHER INFORMATION CONTACT: 

Michael Babich, Directorate for Health 

Sciences, Consumer Product Safety 

Commission, Bethesda, MD 20814; 

telephone (301) 504–7253; email: 

mbabich@cpsc.gov. 

SUPPLEMENTARY INFORMATION: Section 

108 of the CPSIA permanently prohibits 

the sale of any ‘‘children’s toy or child 

care article’’ containing more than 0.1 

percent of each of three specified 

phthalates: Di- (2-ethylhexyl) phthalate 

(DEHP), dibutyl phthalate (DBP), and 

benzyl butyl phthalate (BBP). Section 

108 of the CPSIA also prohibits, on an 

interim basis, the sale of any ‘‘children’s 

toy that can be placed in a child’s 

mouth’’ or ‘‘child care article’’ 

containing more than 0.1 percent of 

each of three additional phthalates: 

Diisononyl phthalate (DINP), diisodecyl 

phthalate (DIDP), and di-n-octyl 

phthalate (DnOP). 

Moreover, section 108 of the CPSIA 

requires the Commission to convene a 

CHAP ‘‘to study the effects on children’s 

health of all phthalates and phthalate 

alternatives as used in children’s toys 

and child care articles.’’ The CPSIA 

requires the CHAP to complete an 

examination of the full range of 

phthalates that are used in products for 

children and: 

• Examine all of the potential health 

effects (including endocrine-disrupting 

effects) of the full range of phthalates; 

• Consider the potential health effects 

of each of these phthalates, both in 

isolation, and in combination with other 

phthalates; 

• Examine the likely levels of 

children’s, pregnant women’s, and 

others’ exposure to phthalates, based 

upon a reasonable estimation of normal 

and foreseeable use and abuse of such 

products; 

• Consider the cumulative effect of 

total exposure to phthalates, both from 

children’s products and from other 

sources, such as personal care products; 

• Review all relevant data, including 

the most recent, best-available, peerreviewed, scientific studies of these 

phthalates and phthalate alternatives 

that employ objective data-collection 

practices or employ other objective 

methods; 

• Consider the health effects of 

phthalates not only from ingestion, but 

also as a result of dermal, hand-tomouth, or other exposure; 

• Consider the level at which there is 

a reasonable certainty of no harm to 

children, pregnant women, or other 

susceptible individuals and their 

offspring, considering the best available 

science, and using sufficient safety 

factors to account for uncertainties 

regarding exposure and susceptibility of 

children, pregnant women, and other 

potentially susceptible individuals; and 

• Consider possible similar health 

effects of phthalate alternatives used in 

children’s toys and child care articles. 

The CPSIA contemplates completion 

of the CHAP’s examination within 18 

months of the panel’s appointment on 

April 14, 2010. The CHAP has an 

additional 6 months to complete its 

final report to the Commission. The 

CHAP must review prior work on 

phthalates by the Commission, but it is 

not to be considered determinative 

because the CHAP’s examination must 

be conducted de novo. 

The CHAP must make 

recommendations to the Commission 

regarding any phthalates (or 

combinations of phthalates), in addition 

to those identified in section 108 of the 

CPSIA, or phthalate alternatives that the 

panel determines should be prohibited 

from use in children’s toys or child care 

articles, or otherwise restricted. The 

CHAP members were selected by the 

Commission from scientists nominated 

by the National Academy of Sciences. 

See 15 U.S.C. 2077, 2030(b). 

The CHAP met previously in April, 

July, and December 2010, March, July, 

and November 2011, and in February 

2012, at the CPSC’s offices in Bethesda, 

MD, and by teleconference in November 

2010, September 2011, December 2011, 

and February 2012. The CHAP heard 

testimony from interested parties at the 

July 2010, and November 2011, 

meetings. There will not be any 

opportunity for public comment during 

the April 2012 teleconference. 

Dated: March 23, 2012. 

Alberta E. Mills, 

Acting Secretary, Consumer Product Safety 

Commission. 

[FR Doc. 2012–7489 Filed 3–28–12; 8:45 am] 

BILLING CODE 6355–01–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Defense Business Board (DBB); Notice 

of Meeting 

AGENCY: DoD. 

ACTION: Meeting notice. 

SUMMARY: Under the provisions of the 

Federal Advisory Committee Act of 

1972 (5 U.S.C., Appendix, as amended), 

the Government in the Sunshine Act of 

1976 (5 U.S.C. 552b, as amended), and 

41 CFR 102–3.150, the Department of 

Defense announces the following 

Federal advisory committee meeting of 

the Defense Business Board (DBB). 

DATES: The public meeting of the 

Defense Business Board (hereafter 

referred to as ‘‘the Board’’) will be held 

on Thursday, April 19, 2012. The 

meeting will begin at 9 a.m. and end at 

10:45 a.m. (Escort required; see 

guidance in SUPPLEMENTARY

INFORMATION, ‘‘Public’s Accessibility to 

the Meeting.’’) 

ADDRESSES: Room 3E863 in the 

Pentagon, Washington, DC (escort 

required; see guidance in 

SUPPLEMENTARY INFORMATION, ‘‘Public’s 

Accessibility to the Meeting’’). 

FOR FURTHER INFORMATION CONTACT: The 

Board’s Designated Federal Officer 

mstockstill on DSK4VPTVN1PROD with NOTICES